Tulobuterol

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Tulobuterol
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Inhaled, oral
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC12H18ClNO
Molar mass227.730 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Tulobuterol

Articles

Most recent articles on Tulobuterol

Most cited articles on Tulobuterol

Review articles on Tulobuterol

Articles on Tulobuterol in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tulobuterol

Images of Tulobuterol

Photos of Tulobuterol

Podcasts & MP3s on Tulobuterol

Videos on Tulobuterol

Evidence Based Medicine

Cochrane Collaboration on Tulobuterol

Bandolier on Tulobuterol

TRIP on Tulobuterol

Clinical Trials

Ongoing Trials on Tulobuterol at Clinical Trials.gov

Trial results on Tulobuterol

Clinical Trials on Tulobuterol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tulobuterol

NICE Guidance on Tulobuterol

NHS PRODIGY Guidance

FDA on Tulobuterol

CDC on Tulobuterol

Books

Books on Tulobuterol

News

Tulobuterol in the news

Be alerted to news on Tulobuterol

News trends on Tulobuterol

Commentary

Blogs on Tulobuterol

Definitions

Definitions of Tulobuterol

Patient Resources / Community

Patient resources on Tulobuterol

Discussion groups on Tulobuterol

Patient Handouts on Tulobuterol

Directions to Hospitals Treating Tulobuterol

Risk calculators and risk factors for Tulobuterol

Healthcare Provider Resources

Symptoms of Tulobuterol

Causes & Risk Factors for Tulobuterol

Diagnostic studies for Tulobuterol

Treatment of Tulobuterol

Continuing Medical Education (CME)

CME Programs on Tulobuterol

International

Tulobuterol en Espanol

Tulobuterol en Francais

Business

Tulobuterol in the Marketplace

Patents on Tulobuterol

Experimental / Informatics

List of terms related to Tulobuterol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tulobuterol (INN) is a long-acting beta2-adrenergic receptor agonist, marketed in Japan as a transdermal patch under the name Hokunalin tape. Currently, it is only legal in 6 countries: Japan, Germany, China, Bangladesh, Pakistan, and Venezuela.

References

Template:Asthma and copd rx